+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Eubiotics Market Size, Share & Industry Trends Analysis Report By Product, By Application, By Form, By End-use, By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 96 Pages
  • May 2022
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5615875
The Europe Eubiotics Market is expected to witness market growth of 6.9% CAGR during the forecast period (2022-2028).

Symbiotic, polyphenols, essential oils, and organic acids can all aid animals maintain intestinal integrity. However, correct replacement product selection is a learning experience that must be based on field observations and will vary depending on various parameters such as animal welfare, food, and genetics. Since the operation of the digestive system is defined by many various interactions and a plethora of variables, it is challenging to think of a single strategy to substitute the use of antibiotics due to the multiple issues affecting chickens in commercial production.

A conceptual framework is crucial to an accurate and appropriate assessment of eubiotics' activities. This should be accompanied by a conceptual assessment that includes retraining of engineers and manufacturers who are still indoctrinated in the era of antibiotics.

AGPs have a visible effect only when the husbandry of animals is inadequate. Cromwell's research found that improving farming conditions is a definite prerequisite for eradicating antibiotics from animal production. Under ideal conditions and diets, eubiotics may replace antibiotic activity.

Farmers that produce animal feed must adhere to a set of rules to ensure that the feed delivered to animals is safe and that feed item can be tracked in the event of a safety incident. The regulation supplements the Food Hygiene Regulations' standards for food production. All animal feed farms must be licensed by the proper enforcement agency. Farmers must follow basic hygienic standards regarding the feed they use or cultivate and ensure that dangers are effectively controlled as primary producers that are not mixing with additives and pre-mixtures. These procedures include preventing feed contamination and spoiling, maintaining records of feed consumed or sold, and cleaning materials used for mixing, storing or transporting feed.

The EU's restriction on processed animal protein (PAP) in poultry and pig feed could be lifted soon. In the next months, the Standing Committee for Animal Feed is scheduled to consider a proposal for a regulation allowing poultry PAPs in pig feed and pig PAPs in poultry feed for approval by written procedure. The 2001 BSE legislation established a restriction on animal proteins in farm animal feed, and the only reauthorizations since then have been for pig and poultry PAPs in aquaculture feed in 2013. Despite some good environmental consequences of farming systems, there are also social concerns about animal welfare and environmental difficulties.

The Germany market dominated the Europe Eubiotics Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $675.3 million by 2028. The UK market is estimated to grow at a CAGR of 6% during (2022 - 2028). Additionally, The France market is expected to witness a CAGR of 7.7% during (2022 - 2028).

Based on Product, the market is segmented into Probiotics, Organic Acids, Phytogenic, Prebiotics, and Enzymes. Based on Application, the market is segmented into Gut Health, Immunity, Yield, and Others. Based on Form, the market is segmented into Solid and Liquid. Based on End-use, the market is segmented into Poultry Feed, Swine Feed, Cattle Feed, Aquatic Feed, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke DSM N.V., Novozymes A/S, BASF SE, DuPont de Nemours, Inc., Chr. Hansen holding A/S, Lallemand, Inc., Lesaffre Group, Kemin Industries, Inc., Cargill Corporation, and Calpis Co., Ltd.

By Product

  • Probiotics
  • Organic Acids
  • Phytogenic
  • Prebiotics
  • Enzymes

By Application

  • Gut Health
  • Immunity
  • Yield
  • Others

By Form

  • Solid
  • Liquid

By End-use

  • Poultry Feed
  • Swine Feed
  • Cattle Feed
  • Aquatic Feed
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players


List of Companies Profiled in the Report:

  • Koninklijke DSM N.V.
  • Novozymes A/S
  • BASF SE
  • DuPont de Nemours, Inc.
  • Chr. Hansen holding A/S
  • Lallemand, Inc.
  • Lesaffre Group
  • Kemin Industries, Inc.
  • Cargill Corporation
  • Calpis Co., Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Eubiotics Market, by Product
1.4.2 Europe Eubiotics Market, by Application
1.4.3 Europe Eubiotics Market, by Form
1.4.4 Europe Eubiotics Market, by End-use
1.4.5 Europe Eubiotics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Eubiotics Market
Chapter 4. Europe Eubiotics Market by Product
4.1 Europe Probiotics Market by Country
4.2 Europe Organic Acids Market by Country
4.3 Europe Phytogenic Market by Country
4.4 Europe Prebiotics Market by Country
4.5 Europe Enzymes Market by Country
Chapter 5. Europe Eubiotics Market by Application
5.1 Europe Gut Health Market by Country
5.2 Europe Immunity Market by Country
5.3 Europe Yield Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe Eubiotics Market by Form
6.1 Europe Solid Market by Country
6.2 Europe Liquid Market by Country
Chapter 7. Europe Eubiotics Market by End-use
7.1 Europe Poultry Feed Market by Country
7.2 Europe Swine Feed Market by Country
7.3 Europe Cattle Feed Market by Country
7.4 Europe Aquatic Feed Market by Country
7.5 Europe Others Market by Country
Chapter 8. Europe Eubiotics Market by Country
8.1 Germany Eubiotics Market
8.1.1 Germany Eubiotics Market by Product
8.1.2 Germany Eubiotics Market by Application
8.1.3 Germany Eubiotics Market by Form
8.1.4 Germany Eubiotics Market by End-use
8.2 UK Eubiotics Market
8.2.1 UK Eubiotics Market by Product
8.2.2 UK Eubiotics Market by Application
8.2.3 UK Eubiotics Market by Form
8.2.4 UK Eubiotics Market by End-use
8.3 France Eubiotics Market
8.3.1 France Eubiotics Market by Product
8.3.2 France Eubiotics Market by Application
8.3.3 France Eubiotics Market by Form
8.3.4 France Eubiotics Market by End-use
8.4 Russia Eubiotics Market
8.4.1 Russia Eubiotics Market by Product
8.4.2 Russia Eubiotics Market by Application
8.4.3 Russia Eubiotics Market by Form
8.4.4 Russia Eubiotics Market by End-use
8.5 Spain Eubiotics Market
8.5.1 Spain Eubiotics Market by Product
8.5.2 Spain Eubiotics Market by Application
8.5.3 Spain Eubiotics Market by Form
8.5.4 Spain Eubiotics Market by End-use
8.6 Italy Eubiotics Market
8.6.1 Italy Eubiotics Market by Product
8.6.2 Italy Eubiotics Market by Application
8.6.3 Italy Eubiotics Market by Form
8.6.4 Italy Eubiotics Market by End-use
8.7 Rest of Europe Eubiotics Market
8.7.1 Rest of Europe Eubiotics Market by Product
8.7.2 Rest of Europe Eubiotics Market by Application
8.7.3 Rest of Europe Eubiotics Market by Form
8.7.4 Rest of Europe Eubiotics Market by End-use
Chapter 9. Company Profiles
9.1 Koninklijke DSM N.V.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisitions and Mergers:
9.1.5.3 Product Launches and Product Expansions:
9.2 Novozymes A/S
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 BASF SE
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.4 DuPont de Nemours, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.5 Chr. Hansen Holding A/S
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Lallemand, Inc.
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Partnerships, Collaborations, and Agreements:
9.7 Lesaffre Group
9.7.1 Company Overview
9.7.2 Recent strategies and developments:
9.7.2.1 Partnerships, Collaborations, and Agreements:
9.8 Kemin Industries, Inc.
9.8.1 Company Overview
9.8.2 Recent strategies and developments:
9.8.2.1 Product Launches and Product Expansions:
9.9 Cargill Corporation
9.9.1 Company Overview
9.9.2 Recent strategies and developments:
9.9.2.1 Product Launches and Product Expansions:
9.10. Calpis Co., Ltd. (Asahi Group Holdings, Ltd.)
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental Analysis
9.10.4 Recent strategies and developments:
9.10.4.1 Approvals and Trials:

Companies Mentioned

  • Koninklijke DSM N.V.
  • Novozymes A/S
  • BASF SE
  • DuPont de Nemours, Inc.
  • Chr. Hansen holding A/S
  • Lallemand, Inc.
  • Lesaffre Group
  • Kemin Industries, Inc.
  • Cargill Corporation
  • Calpis Co., Ltd.

Methodology

Loading
LOADING...